Novartis Taps Genomics Collaborative For Two-Year Target Validation Project

The Novartis Institutes for BioMedical Research will use Genomics Collaborative’s Global Repository of human DNA, sera, and tissue samples in a research program to prioritize drug targets before they enter clinical trials.

The non-exclusive research collaboration will initially run for two years, with the option to extend for two more years. It will cover up to four therapeutic areas, beginning with type 2 diabetes.